Page thématique

Veterinary medicine - ANMV

The French Agency for Veterinary Medicinal Products (ANMV), within ANSES, is the Competent Authority in France for risk assessment and management with regard to veterinary medicinal products.

In this capacity, the Government was keen for the ANMV to strive for constant improvement of its services with a view to protecting public health as well as the health and welfare of animals.

To this end, the ANMV must enforce the current applicable legal provisions in an independent, competent and impartial manner. Click here to find out more about the Agency’s history.

The ANMV is located in Javené, near Fougères (Ille-et-Vilaine) and has 80 staff members, mainly specialised scientists.

 

 

 

 

Declaring an adverse effect that may be due to a veterinary medicinal product (in French)
Sector professionals

List of veterinary pharmaceutical manufacturers and wholesalers (in French)

 

Marketing authorization (AMM) no./National Working Group (GTIN) code correspondence table (in French)

News

Antimicrobial resistance in animal health: 2024 review
18/11/2025
Research

Antimicrobial resistance in animal health: 2024 review

To mark World Antibiotic Awareness Week, ANSES is publishing the annual results from the schemes it coordinates on the monitoring of veterinary...
29/09/2022
News

Advertising for veterinary medicinal products — The fundamentals

The provisions relating to the advertising of veterinary medicinal products are regulated by the European Regulation 2019/6 and supplemented, in...

Decryption

31/01/2025

Update on the assessment and authorisation of veterinary vaccines

Veterinary vaccines protect animals both individually and collectively against diseases caused by viral, bacterial or parasitic pathogens and, in the case of zoonoses, prevent the risk of transmission…
29/11/2022

ANSES's activities in the area of antimicrobial resistance and veterinary antimicrobials

The multiplication of bacterial strains that are resistant to antibiotics calls into question the efficacy of these treatments. The issue of antimicrobial resistance presents a major challenge for…
29/11/2022

Eleven questions on antimicrobial resistance in animal health

Antimicrobial resistance is a major issue for both human and animal health. The emergence and spread of bacterial strains that are resistant to antibiotics call into question the efficacy of these…
30/08/2022

Head lice: never use animal treatments on children

Every year, cases of use of antiparasitic products intended for pets to treat head lice in children are reported. The Agency emphasises that antiparasitic treatments, insecticides or acaricides for…
08/01/2021

Antimicrobial resistance: a major issue for animals and humans

Antimicrobial resistance is a major issue for both human and animal health. The emergence and spread of antibiotic-resistant bacterial strains call into question the efficacy of these treatments…
13/04/2018

The proper use of ectoparasiticides in domestic animals

External parasites can cause serious illnesses in animals, or even lead to diseases that are transmissible to humans. To control and/or prevent these diseases, a range of veterinary medicinal products…
30/07/2015

ANSES: a brief outline

Created on 1 July 2010, the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) is an independent scientific body which performs its risk assessment, reference and research…
18/05/2015

Head lice treatments

Antiparasitics, insecticides and anti-mite treatments intended for pets should never be used on humans, especially children. Veterinary medicinal products obtain marketing authorisation (MA) prior to…

Publications

document

ANSES Report: Post-MA surveillance of veterinary medicinal products - Annual report 2019

Date de mise en ligne

Numéro de saisine

Pharmacovigilance2019